Thomas Mueller
Thorlabs (Germany)(DE)
Publications by Year
Research Areas
Heart Failure Treatment and Management, IL-33, ST2, and ILC Pathways, Peripheral Artery Disease Management, Eosinophilic Esophagitis, Cardiovascular Function and Risk Factors
Most-Cited Works
- → Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations(2019)762 cited
- → Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior(2010)692 cited
- → Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure(2008)381 cited
- → Comparison of the Biomedica NT-proBNP Enzyme Immunoassay and the Roche NT-proBNP Chemiluminescence Immunoassay: Implications for the Prediction of Symptomatic and Asymptomatic Structural Heart Disease(2003)359 cited
- → Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the World(2013)250 cited
- → Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study(2013)237 cited
- → Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma — The Presage™ ST2 assay(2009)235 cited
- → Comparative Evaluation of B-Type Natriuretic Peptide, Mid-Regional Pro-A-type Natriuretic Peptide, Mid-Regional Pro-Adrenomedullin, and Copeptin to Predict 1-Year Mortality in Patients With Acute Destabilized Heart Failure(2007)226 cited
- → Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis(2016)215 cited
- → Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm(2010)215 cited